PROM1 and central nervous system cancer: Recent studies have identified CD133+ glioma-initiating cells (GICs) that exhibit stem cell-like properties3, 4.These GICs possess capacities for tumorigenesis, self-renewal, and differentiation into multiple cell types, such as neurons, astrocytes, and oligodendrocytes4, 5.